HOME > TOP STORIES
TOP STORIES
-
BUSINESS Sumitomo Dainippon Reorganizes Drug Discovery Research System; Accelerating Decision-Making: Pres.
April 18, 2018
-
REGULATORY Pharma Leaders Air Grievances on Pricing Reform Package at New MHLW Confab
April 17, 2018
-
BUSINESS Takeda CEO Eager to Lure More Partners to Shonan iPark, Says Diversity Is Source of Creativity
April 16, 2018
-
BUSINESS Shonan Health Innovation Park Marks Grand Opening: Takeda
April 16, 2018
-
ORGANIZATION PhRMA Chief Warns of Serious Implications for Japan Market after 2018 Pricing Reform
April 13, 2018
-
REGULATORY Chuikyo Payer Rep Questions New Premium System for Cost-Based Pricing Method
April 12, 2018
-
REGULATORY MOF Calls for Using CEA to Make Reimbursement Decisions for Pricy Drugs
April 12, 2018
-
REGULATORY Pricing OK’ed for Dupixent, Tecentriq, Lynparza, and More; Parmodia Skips Listing Yet Again
April 11, 2018
-
REGULATORY MHLW to Launch New Public-Private Confab Focusing on Drug Pricing
April 10, 2018
-
ORGANIZATION Company Category Criteria for Price Maintenance Premium Tough on Ophthalmic Drug Makers: Industry Group
April 9, 2018
-
BUSINESS Alfresa to Fully Introduce Distribution Cost Analysis System; Will “Raise Reps’ Awareness of Importance of Price Negotiations”: Pres.
April 9, 2018
-
REGULATORY MEXT to Support Establishment of “Open Innovation Organizations” at Universities
April 6, 2018
-
REGULATORY MHLW Panel to Kick Off Debates on Amendment of Pharmaceuticals and Medical Devices Law
April 5, 2018
-
TRENDS Eisai’s Nichi-Iko Deal Marks Watershed in Generic Biz of Research-Driven Makers
April 3, 2018
-
BUSINESS Keytruda Filed for Tumor-Agnostic Indication in Japan
April 2, 2018
-
TRENDS Lilly Japan Joins Top 10 List for 1st Time, Sales Triple in 10 Years on Successive Launches
March 30, 2018
-
BUSINESS Eisai to Quit Generic Supply Biz, Transfer Subsidiary to Nichi-Iko
March 29, 2018
-
BUSINESS Takeda Mulls Takeover Bid for Shire
March 29, 2018
-
REGULATORY Sakigake Status Goes to World’s 1st Renal-Function Improving Agent, BBB-Penetrating Hunter Syndrome Med and 4 More Drugs
March 28, 2018
-
BUSINESS JCR Shooting for Big Chunk of 900 Billion Yen Global Lysosome Storage Disease Market with J-Brain Cargo
March 27, 2018
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
